Thiolated Eudragit-Coated Chitosan Microspheres as an Oral Drug Delivery System

Article Preview

Abstract:

The aim of this study is to prepare mucoadhesive chitosan microspheres for protein drug to deliver to intestine through oral administration. The thiolated Eudragit was synthesized by reaction between L-cysteine hydrochloride and Eudragit® L-100. About 8 mol-% of cysteine was introduced to the Eudragit-cysteine conjugate. The conjugate was used to coat bovine serum albumin (BSA)-loaded chitosan microspheres. The average particle sizes of BSA-loaded thiolated Eudragit-coated chitsoan microspheres (TECMs) were 4.06±0.74 .m and the uniform sizedistribution was shown. The in vitro release of BSA from BSA-loaded TECMs was pH-dependent. Our results indicated that thiolated Eudragit might be a good candidate as a coating material for oral delivery of protein drug owing to mucoadhesive and pH-sensitive properties.

You might also be interested in these eBooks

Info:

Periodical:

Key Engineering Materials (Volumes 342-343)

Pages:

445-448

Citation:

Online since:

July 2007

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2007 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] P. Arbo´s, M.A. Arangoa, M.A. Campanero, J.M. Irache: Int. J. Pharm. Vol. 242 (2002), p.129.

Google Scholar

[2] H. Takeuchi, H. Yamamoto, Y. Kawashima: Adv. Drug Deliv. Rev. Vol. 47 (2001), p.39.

Google Scholar

[3] J. Kreuter: Adv. Drug Deliv. Rev. Vol. 7 (1991), p.71.

Google Scholar

[4] P. Couvreur, F. Puisieux: Adv. Drug Deliv. Rev. Vol. 10 (1993) p.141.

Google Scholar

[5] S. Sakuma, R. Sudo, N. Suzuki, H. Kikuchi, K. Hiwatari, M. Akashi, M. Hayashi: Int. J. Pharm. Vol. 177 (1999), p.161.

Google Scholar

[6] A. H. Krauland, A. Bernkop-Schnurch: Eur J Pharm Biopharm. Vol. 57 (2004), p.181.

Google Scholar

[7] A. Bernkop-Schnürch, M. Hornof, T. Zoidl: Int. J. Pharm. Vol. 260 (2003), p.229.

Google Scholar

[8] Jiang H.L., Park I.K., Shin N.R., Kang S. G. , Yoo H.S., Kim S. I., Suh S. B., Akaike T., Cho C.S.: Eur. J. Pharm. Biopharm., Vol. 58 (2004) p.471.

Google Scholar

[9] V. M. Leitner, G. F. Walker, A. Bernkop-Schnurch: Eur J Pharm Biopharm. Vol. 56 (2003), p.207.

Google Scholar

[10] C. E. Kast, D. Guggi, N. Langoth, A. Bernkop-Schnurch: Pharm. Res. 20 (2003), p.931.

Google Scholar

[11] T.L. Bowersock, S. Martin: Adv Drug Deliv. Rev. Vol. 38 (1999), pp.167-70 Accumulative release (%) Time (h) pH 2. 0 pH 4. 0 pH 7. 4 Fig. 4. In vitro release of BSA from BSA-loaded TECMs at pH 7. 4, pH 4. 0 and pH 2. 0 at 37℃.

DOI: 10.1021/bc070052e.s001

Google Scholar